Clinical Trial Update: A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating two doses of vandetanib (ZD6474) in combination with FOLFOX versus FOLFOX alone for colorectal cancer; study completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFOX
• Vandetanib (vandetanib)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Colorectal, Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-05-24